FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Levothyroxine sodium anhydrous 100 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Levothyroxine sodium anhydrous 100 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely quinagolide (as quinagolide hydrochloride) 75 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely quinagolide (as quinagolide hydrochloride) 75 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Salbutamol (as salbutamol sulfate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Salbutamol (as salbutamol sulfate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Pergolide (as pergolide mesilate) 250 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Pergolide (as pergolide mesilate) 250 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Quetiapine (as quetiapine fumarate) 150 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Quetiapine (as quetiapine fumarate) 150 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Reboxetine (as reboxetine mesilate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Reboxetine (as reboxetine mesilate) 4 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Levothyroxine sodium anhydrous 25 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Levothyroxine sodium anhydrous 25 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluphenazine hydrochloride 1.5 mg and nortriptyline (as nortriptyline hydrochloride) 30 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Fluphenazine hydrochloride 1.5 mg and nortriptyline (as nortriptyline hydrochloride) 30 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluphenazine hydrochloride 1.5 mg and nortriptyline (as nortriptyline hydrochloride) 30 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lapatinib (as lapatinib ditosylate) 250 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Lapatinib (as lapatinib ditosylate) 250 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Darunavir (as darunavir ethanolate) 600 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Darunavir (as darunavir ethanolate) 600 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fenoprofen (as fenoprofen calcium) 300 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Levothyroxine sodium anhydrous 50 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Levothyroxine sodium anhydrous 50 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 57 of 87 Next End


This concept is not in any reference sets

Back to Start